NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Neuroinflammation plays a pivotal role in the pathogenesis of neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD). Current pharmacological interventions, such as NSAIDs and corticosteroids, are limited by systemic toxicity and insufficient efficacy in targeting chronic neuroinflammatory processes. Emerging evidence highlights the therapeutic potential of plant-derived essential oils and fatty acids in modulating neuroinflammatory pathways through multi-target mechanisms. Essential oils enriched with terpenoids (e.g., carnosic acid, eugenol) attenuate microglial activation and cytokine production by suppressing NF-κB and MAPK signaling, while polyunsaturated fatty acids (PUFAs), particularly omega-3, enhance blood-brain barrier integrity and promote the resolution of oxidative stress via Nrf2-mediated antioxidant defenses. Preclinical studies demonstrate that these compounds reduce Aβ plaque burden, protect dopaminergic neurons, and ameliorate cognitive deficits in animal models of AD and PD. This review provides a comprehensive evaluation of the multifaceted roles of essential oils and fatty acids in combating neuroinflammation and their potential as therapeutic agents. Furthermore, this sets a foundation for further research into translating these natural products into clinical applications in modulating neuroinflammation and related disorders.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.